Skip to main content

Month: August 2022

QCI Releases Video of Landmark Moment in Quantum Computing

First Pure Quantum Solution of a Complex Commercial Problem with Over 3,800 Variables Addresses Quantum’s Ability to Solve Large Scale Problems Today LEESBURG, Va., Aug. 15, 2022 (GLOBE NEWSWIRE) — Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT), a leader in accessible quantum computing, today shared a video demonstrating what it believes is a landmark achievement in the field. In the video, QCI CTO/COO William McGann reveals that the Company has solved a sensor optimization problem with over 3,800 variables including 500 constraints in just over six minutes. This achievement demonstrates the first full-quantum solution, delivering a feasible and optimal result that is superior to previous comparative classical and hybrid approaches. The video (linked here) also features Dr. McGann presenting data that shows full...

Continue reading

HeartCore Reports Second Quarter 2022 Financial Results

NEW YORK and TOKYO, Aug. 15, 2022 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (“HeartCore” or “the Company”), a leading software development company, today reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 and Recent Operational HighlightsGrew total number of global enterprise customers to 877 as of June 30, 2022. Launched “truRes-12K”, the world’s first 12k-compatible real-time 360° virtual reality camera. Released Robot Store, an e-commerce website that provides Robotic Automation Process (“RPA”) services to its Japanese enterprise-level customers. Launched the Human Resources Digital Transformation Development Service, to help implement and advance HR related digital transformation initiatives for its enterprise-level customers. Authorized a $3.5 million share repurchase program. Signed...

Continue reading

Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial Results

WARREN, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2022. “The Bellerophon team continues to advance our late-stage INOpulse® inhaled nitric oxide therapy platform for the treatment of fibrotic interstitial lung disease, or fILD, and pulmonary hypertension associated with sarcoidosis, or PH-Sarc,” said Naseem Amin, M.D., Chairman of Bellerophon’s Board of Directors. “Enrollment is steadily proceeding in our Phase 3 REBUILD study in fILD, which is evaluating the change in moderate to vigorous physical activity following treatment with INOpulse....

Continue reading

WaveDancer Releases Second Quarter 2022 Results

$500,000 of Revenue Recognized from Blockchain Platform Development as Company Nears Full Production; Revenue up 44% from First Quarter FAIRFAX, Va., Aug. 15, 2022 (GLOBE NEWSWIRE) — WaveDancer (NASDAQ: WAVD), reported its results for the second quarter ended June 30, 2022, which was characterized by continued investment in its software development team and strategic efforts focused on maintaining and growing profitability in the Company’s professional services work. The Company recognized significant revenues after achieving substantial project milestones on their key United States government contract to bring a blockchain-enabled supply chain and logistics platform into full production. WaveDancer CEO Jamie Benoit commented, “The various investments we have made in WaveDancer are helping establish a strong foundation for growth....

Continue reading

Inuvo Revenue Increases 79.3% Year-Over-Year to $22.7 Million for the Second Quarter of 2022

Inuvo management to host conference call at 10:00 AM ET today, Monday, August 15, 2022 LITTLE ROCK, Ark., Aug. 15, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today provided a business update, and announced its financial results for the second quarter ended June 30, 2022. Richard Howe, CEO of Inuvo, stated, “We had another exceptionally strong quarter as demonstrated by a 79.3% year-over-year increase in revenue to $22.7 million for the three months ended June 30, 2022. We also achieved a 77.4% year-over-year increase in revenue to $41.3 million for the six months ended June 30, 2022. Importantly, we have realized approximately 15% compounded quarterly growth rate over the two-year period between Q2...

Continue reading

Edible Garden Continues Organic Growth with Revenue Increasing 7.5% Year-Over-Year for the Second Quarter of 2022 and New Expansion Initiatives Underway

Conference Call to Be Held Today at 11:00 am ET BELVIDERE, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce, today provided a business update and reported financial results for the three months ended June 30, 2022. Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “We continue to gain traction in the market, as evidenced by our solid year-over-year and sequential revenue growth, which does not reflect the deployment of the capital raised through our successful initial public offering (IPO) and listing on the Nasdaq in the second quarter. We are in the early stages of prudently deploying the capital, which we believe will help us further...

Continue reading

ContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Focused on advancement of lead programs, exebacase and CF-370, into new clinical studies YONKERS, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced financial results and business updates for the second quarter ended June 30, 2022. “Despite the recent setback from the interim futility analysis of our Phase 3 DISRUPT superiority study of intravenous (IV) exebacase, we continue to advance our lead programs toward new clinical studies. We expect to file with regulatory authorities later this year to initiate a study of intra-articular exebacase in...

Continue reading

Free Flow, Inc. Announces Heavy Melting Scrap Metal Purchase Agreement Valued at $14 Million

KING GEORGE, VA, Aug. 15, 2022 (GLOBE NEWSWIRE) — Free Flow, Inc. (OTCQB: FFLO), is pleased to announce a new heavy melting scrap metal purchasing agreement valued at $14 million. The purchasing agreement is expected to involve a total of approximately 45,000 metric tons. Mr. Sabir Saleem, Free Flow, Inc. Chief Executive Officer stated, “Adding a new scrap metal purchasing agreement worth $14 million in contract value is another significant milestone for Free Flow as we continue to enhance shareholder value.” The contracted client is a major international supplier of commodities to industrial consumers, and its management possess over a 30-year history in bulk commodity trading and shipping. Pricing for the scrap metal will be determined by the international published price index as reported by COMEX (Commodity Exchange Inc.)...

Continue reading

AS Tallinna Vesi submitted an application to the Competition Authority to adjust the price for water services

AS Tallinna Vesi submitted an application to the Competition Authority on 15/08/2022 to increase the price for water services by 26 cents per cubic metre on average. According to Aleksandr Timofejev, Chairman of the Board of Tallinna Vesi, the price of electricity has increased approximately 3.5 times since the current price for water services provided by the Company was applied. “With inflation of nearly 23% and in a situation where high electricity prices affect all sectors, the current price for water services no longer covers justified costs. The electricity accounts for about 25% of our operational costs and in order to ensure the high quality and consistency of the service, we must apply to the Competition Authority for an increase in the price for water services to cover the costs.” The price for water services includes the water...

Continue reading

Mativ to Participate in Sidoti’s August 2022 Micro-Cap Virtual Conference

Alpharetta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Mativ Holdings, Inc. (“MATV” or the “Company”) (NYSE: MATV) announced today that the Company is scheduled to participate in the Sidoti August 2022 Micro-Cap Virtual Conference. The presentation will be on Wednesday, August 17, beginning at 8:30 am E.T. The live webcast of the presentation can be accessed using the following link https://sidoti.zoom.us/webinar/register/WN_Cwr13gChR_-5PPFcpC8Jcw or through the Company’s investor relations website at https://ir.mativ.com. About Mativ Mativ Holdings, Inc. is a global leader in specialty materials headquartered in Alpharetta, Georgia. The Company offers a wide range of critical components and engineered solutions to solve our customers’ most complex challenges. With over 7,500 employees worldwide, we manufacture on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.